Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain. [PDF]
Ma S+6 more
europepmc +1 more source
Use of the Human Coronavirus 2012 (MERS) GeneSig kit for MERS-CoV detection
Rouba Hoteit, Dina Shammaa, Rami Mahfouz
openalex +1 more source
Correction: Fan et al. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. <i>Viruses</i> 2018, <i>10</i>, 448. [PDF]
Fan C+12 more
europepmc +1 more source
Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor. [PDF]
Failayev H, Ganoth A, Tsfadia Y.
europepmc +1 more source
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. [PDF]
Wang G+8 more
europepmc +1 more source
Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV. [PDF]
Almansour I, Jermy BR.
europepmc +1 more source
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen. [PDF]
Ahuja R+11 more
europepmc +1 more source
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023. [PDF]
Ogoti BM+15 more
europepmc +1 more source
MERS-CoV-nsp5 expression in human epithelial BEAS 2b cells attenuates type I interferon production by inhibiting IRF3 nuclear translocation. [PDF]
Zhang Y+3 more
europepmc +1 more source